Skip to main content

Table 1 Baseline characteristics of the study population, according to whether a woman had the composite outcome of maternal end-organ injury or death between 20 weeks’ gestation and up to 42 days after birth. All data are shown as a number (%) unless otherwise stated

From: Development and internal validation of a model predicting severe maternal morbidity using pre-conception and early pregnancy variables: a population-based study in Ontario, Canada

Characteristic

With maternal end-organ injury or deatha (N = 1969)

Without maternal end-organ injury or death (N = 632,321)

Standardized difference

Demographic factors, at conception

 Age, y

  Mean ± SD

31.0 ± 5.9

29.6 ± 5.5

0.24

  18–34

1414 (71.8)

512,340 (81.0)

0.22

  35–39

428 (21.7)

100,490 (15.9)

0.15

  40–44

112 (5.7)

18,529 (2.9)

0.14

  ≥ 45

15 (0.8)

962 (0.2)

0.09

 Neighbourhood income quintile (Q)

  Q1 (lowest)

521 (26.5)

145,947 (23.1)

0.08

  Q2

388 (19.7)

128,604 (20.3)

0.02

  Q3

422 (21.4)

129,051 (20.4)

0.03

  Q4

370 (18.8)

128,928 (20.4)

0.04

  Q5 (highest)

268 (13.6)

99,791 (15.8)

0.06

 World region of origin

  Western Nations and Europe

69 (3.5)

27,845 (4.4)

0.05

  Hispanic America

47 (2.4)

14,183 (2.2)

0.01

  Caribbean

60 (3.0)

10,305 (1.6)

0.09

  Sub-Saharan Africa

80 (4.1)

12,073 (1.9)

0.13

  Middle East and North Africa

43 (2.2)

18,138 (2.9)

0.04

  East Asia and Pacific

139 (7.1)

42,556 (6.7)

0.01

  South Asia

166 (8.4)

55,899 (8.8)

0.01

  Canada/Long-term resident

1365 (69.3)

451,322 (71.4)

0.04

Infertility history identified in the index pregnancyb

254 (12.9)

49,231 (7.8)

0.17

 Any infertility treatment

110 (5.6)

18,449 (2.9)

0.13

  IVFc

80 (72.7)

9830 (53.3)

0.41

  Non-IVFc

30 (27.3)

8619 (46.7)

0.41

Obstetrical factors in the index pregnancy

 Parity

  0

1004 (51.0)

299,851 (47.4)

0.07

  1–2

823 (41.8)

297,303 (47.0)

0.11

  ≥ 3

142 (7.2)

35,167 (5.6)

0.07

 Multiple gestation

179 (9.1)

18,149 (2.9)

0.26

 Had a first-trimester prenatal visit

1296 (65.8)

457,620 (72.4)

0.14

 Placental disorderd

160 (8.1)

12,020 (1.9)

0.29

 Median (IQR) gestational age at birth, weeks

38 (36–39)

39 (38–40)

0.51

Obstetrical factors identified in any prior pregnancye

 Unplanned Caesarean birth

340 (35.2)

65,205 (19.6)

0.36

 Severe organ injury

21 (1.1)

482 (0.1)

0.13

 Preeclampsia, eclampsia or HELLP syndrome

29 (3.0)

5038 (1.5)

0.1

 Preterm birth < 37 weeks’ gestation

90 (9.3)

19,958 (6.0)

0.13

 Gestational diabetes mellitus

57 (5.9)

12,512 (3.8)

0.1

 Previous spontaneous abortion

  0

1426 (72.4)

487,379 (77.1)

0.11

  1–2

486 (24.7)

131,660 (20.8)

0.09

  ≥ 3

57 (2.9)

13,167 (2.1)

0.05

  Missing

≤5 (0.0)

116 (0.0)

0.02

Medical factors identified within 365 days before the estimated date of conception in the index birth

 Median (IQR) body mass index, kg/m2f

24.2 (24.2–24.2)

24.2 (24.2–24.2)

0.10

 Body mass index category

  < 18.5 kg/m2

34 (1.7)

11,622 (1.8)

0.01

  18.5–24.9 kg/m2

356 (18.1)

116,614 (18.4)

0.01

  25–29.9 kg/m2

212 (10.8)

56,016 (8.9)

0.06

  > 30 kg/m2

202 (10.3)

44,644 (7.1)

0.11

  Missing

1165 (59.2)

403,425 (63.8)

0.1

 Obese (body mass index > 30 kg/m2 at any visit)f

239 (12.1)

54,493 (8.6)

0.12

 Median (IQR) body mass index, kg/m2 (without replacement)g

25.2 (22.0–30.1)

24.2 (21.3–28.5)

0.17

 Chronic hypertension

156 (7.9)

16,796 (2.7)

0.24

 Renal disease

27 (1.4)

758 (0.1)

0.15

 Diabetes mellitus (non-gestational)

94 (4.8)

10,203 (1.6)

0.18

 Dyslipidemia

51 (2.6)

12,161 (1.9)

0.04

 Cardiovascular morbidityh

122 (6.2)

12,469 (2.0)

0.21

 Systemic lupus erythematosus

14 (0.7)

722 (0.1)

0.09

 Asthma

213 (10.8)

43,376 (6.9)

0.14

 Other medical conditionsi

7 (0.4)

709 (0.1)

0.05

 Alcohol overuse

14 (0.7)

2654 (0.4)

0.04

 Any substance use

76 (3.9)

12,295 (1.9)

0.11

 Any tobacco use

231 (11.7)

72,387 (11.4)

0.01

  1. Abbreviations: SD Standard deviation, IQR Interquartile range, IVF In vitro fertilization, HELLP Haemolysis elevated liver enzymes low platelets
  2. aMaternal end-organ injury or death occurring from 20 weeks’ gestation to 42 days after birth
  3. bIncludes diagnosis of infertility, endometriosis, and polycystic ovarian syndrome
  4. cPercentages are among those who received any infertility treatment
  5. dIncludes placenta praevia, placenta accreta, vasa praevia, and other placental disorders
  6. eAmong 333,435 parous women
  7. fBody mass index was known among 804 (40.8%) women with the composite outcome, and 228,896 (36.2%) who did not have the composite outcome. For women with a missing body mass index, or an implausible value < 10 or > 50 kg/m2, a median body mass index of 24.2 kg/m2 was used
  8. gWomen with a missing body mass index, or an implausible value < 10 or > 50 kg/m2, were removed
  9. hIncludes chronic congestive heart failure, congenital heart disease, pulmonary hypertension, coronary artery disease, cardiac dysrhythmia, chronic rheumatic heart diseases, or non-incident stroke or myocardial infarction within the previous 365 days
  10. iIncludes sickle cell disease and HIV